About this trial
Using a bioactive resin composite in subgingival Class II cavities can provide enhanced caries resistance by releasing multiple ions, including fluoride. This approach offers greater resistance to caries due to the incorporation of surface pre-reacted glass filler (S-PRG) technology (Imazato, Nakatsuka et al., 2023).
This type of composite may improve the outcomes of deep subgingival margin elevation, benefiting both restorative success and periodontal health.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult Patient (20-50 years old)
Good oral hygiene (plaque index 0 or 1)
Patient approval
Absence of parafunctional habits and/or bruxism
Disqualifiers
Patients with known allergic or adverse reaction to the tested materials.
Bad oral hygiene
Systematic disease that may affect participation.
Xerostomic patients.
Trial design
Single group
Treatments tested in this trial
Beautifil F00
Other interventionBeautifil F00 is bioactive giomer resin composite.
G-aenial Universal Injectable Flowable Composite
Other interventionNanohybrid resin composite is a type of restorative material that features nano-sized fillers as a main component
Treatment groups
Trial outcomes
Primary outcomes
Recurrent caries
* 0: no evidence of caries continuous along the margin * 1: caries evident continuous with the margin of restoration
Secondary outcomes
1. Post-operative sensitivity. 2. Fracture of Restoration. 3. Bleeding on probing
1. Post-operative sensitivity. * 1: Absent * 2: Present 2. Fracture of Restoration. * 1: Restoration is intact and fully retained. * 2: Restoration is partially retained with some portion of the restoration still intact. * 3: Restoration is completely missing 3. Bleeding on probing * 0: Healthy gums * 1: Bleeding on probing 2:periodontal problem with bone loss
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: